Analysts’ Viewpoint
Rise in demand for biologics and biosimilars is expected to drive the global market during the forecast period. The shift toward single-use technologies to enable faster production timelines is further fueling market expansion. Surge in outsourcing of laboratory services is another major factor propelling global bioprocess containers market growth. Furthermore, newer materials, bag designs, and assembly techniques are being developed to improve the performance of bioprocess containers and enable higher product yields. This is expanding the capabilities of single-use technologies.
However, concerns around the sustainability of single-use technologies and increasing regulatory requirements could pose challenges for market players. Companies would need to work on improving the recyclability and reusability of their single-use products to alleviate sustainability concerns.
The bioprocess containers market includes single-use disposable bags used for the manufacturing of biopharmaceuticals and biological products. These bags are primarily made of plastics such as polyethylene, polypropylene, and polyvinyl chloride.
Increase in demand for biologic drugs and biosimilars is a major bioprocess containers market driver. Single-use bioprocess bags offer benefits such as lower cost, less risk of cross-contamination, and faster production timelines. These eliminate the need for expensive and cumbersome cleaning and sterilization of traditional stainless steel bioreactors.
The COVID-19 pandemic has bolstered market growth, as bioprocess bags help accelerate vaccine development and production using single-use technologies.
Increase in demand for biologics and biosimilars is fueling the global bioprocess containers market size. Biologics are large, complex medicinal products manufactured using biological processes.
Biosimilars are similar versions of original biologics that are developed after the patent on the original biologic expires. Hence, the cost-effectiveness of biosimilars compared to biologics is greater, which is propelling demand for biosimilars.
The global population aged 60 and over is projected to nearly double from 12% to 22% between 2015 and 2050. As people age, they become more prone to chronic diseases that can be treated with biologics. Hence, increase in incidence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, is a key factor boosting demand for biologics. These conditions often require long-term or life-long treatment, and biologics are increasingly used as effective therapies.
Several companies across industries are opting to outsource their laboratory services to specialized contract research organizations (CROs) and contract manufacturing organizations (CMOs). Outsourcing allows companies to focus on their core competencies while leveraging the expertise and infrastructure of these service providers.
Demand for bioprocess containers is rising in order to support outsourced research, development, and manufacturing processes. These include 2D bioprocess containers, 3D bioprocess containers, and tanker liners that are required by the CROs and CMOs to deliver their services.
Outsourcing laboratory services offer companies cost advantages. It eliminates the need for substantial investment in laboratory infrastructure, equipment, and skilled personnel. By outsourcing, companies can reduce operational costs, increase flexibility, and access cutting-edge technologies without incurring upfront capital expenditures. This cost-effectiveness drives the adoption of outsourcing, leading to a corresponding demand for bioprocess bags/containers by the service providers.
Based on type, the 2D bioprocess containers segment is projected to account for the largest global bioprocess containers market share from 2023 to 2033. This is ascribed to the simplicity, cost-effectiveness, and widespread commercial availability of 2D bioprocess containers. These factors make 2D bags the preferred choice for most lab-scale and medium-scale bioprocessing applications.
2D containers consist of a flat bottom and sides that are heat-sealed together, forming a simple envelope-like configuration that is easy to manufacture. The relatively low material input and simple design allow 2D bags to offer significant cost savings compared to more complex 3D bioprocess containers. Hence, 2D bags are commercially available in a wide range of sizes and materials to meet various bioprocessing needs.
Based on application, the upstream processes segment dominated the global bioprocess containers industry in 2022. Upstream process includes cell culture and fermentation, which require more consumables such as media bags, feed bags and reservoirs. This drives demand for bioprocess containers in upstream processes compared to downstream processes. Moreover, upstream processes tend to be more variable and complex, involving multiple steps and container types. This leads to greater consumption of bioprocess containers.
As per bioprocess containers market trends, North America accounted for the largest share of more than 30% of the global market in 2022. This is ascribed to presence of leading biologics & biopharmaceutical companies and contract manufacturing organizations; and increase in investment in R&D activities by pharmaceutical companies in the region.
The U.S. dominated the market in North America in 2022. This is ascribed to high demand for single-use containers, as they minimize the risk of contamination and enable quicker production turnaround times. These factors help pharmaceutical companies reduce manufacturing costs and bring products to market more quickly.
Asia Pacific was the fastest growing market in 2022. The market in the region is expected to expand at a CAGR of 11.9% during the forecast period. Rise in investment by key players, increase in R&D expenditure by pharmaceutical companies, and growing biopharmaceutical industry offer lucrative bioprocess containers market opportunities in the region.
China and India are the primary markets in the region. Factors such as rising disposable income, growing healthcare awareness, and increasing government funding for biopharmaceutical research are fueling the growth of the biopharmaceutical industry in Asia Pacific. The region is also witnessing rapid increase in the number of CROs and CMOs, which require single-use bioprocess containers in their manufacturing processes.
China and India provide ample opportunities for outsourcing manufacturing operations due to the availability of affordable skilled labor, low production costs, and government initiatives to attract foreign investments in the pharmaceutical sector. Key players in the market are also focusing on expanding presence in Asia Pacific through partnerships, acquisitions, and contract manufacturing agreements with local companies.
The global market is consolidated, with the presence of small number of key players. New advancements in available products and merger & acquisition are the key strategies adopted by these players.
Sartorius AG, Thermo Fisher Scientific, Inc., Danaher Corporation, Merck KGaA, Corning Incorporated, Saint-Gobain, Avantor, Inc., Parker Hannifin Corporation, Entegris, Inc., Meissner Filtration Products, Inc., Lonza AG, Flexbiosys Inc., ABEC, Inc., and Cellexus are the prominent players in the market.
Each of these players has been profiled in the bioprocess containers market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
|
Size in 2022 |
US$ 2.9 Bn |
|
Forecast (Value) in 2033 |
US$ 9.3 Bn |
|
Growth Rate (CAGR) |
11.1% |
|
Forecast Period |
2023-2033 |
|
Historical Data Available for |
2017-2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Example: Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
It was valued at US$ 2.9 Bn in 2022
It is projected to exceed US$ 9.3 Bn by 2033.
It expanded at a CAGR of 19.1% from 2017 to 2022
It is anticipated to advance at a CAGR of 11.1% from 2023 to 2033.
Increase in demand for biologics & biosimilars and surge in outsourcing of laboratory services.
The 2D bioprocess containers type segment held over 60.0% share in 2022.
North America is likely to account for leading share during the forecast period.
Sartorius AG, Thermo Fisher Scientific, Inc., Danaher Corporation, Merck KGaA, Corning Incorporated, Saint-Gobain, Avantor, Inc., Parker Hannifin Corporation, Entegris, Inc., Meissner Filtration Products, Inc., Lonza AG, Flexbiosys Inc., ABEC, Inc., and Cellexus.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bioprocess Containers Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bioprocess Containers Market Analysis and Forecast, 2017-2033
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Key Industry Events
5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Bioprocess Containers Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017-2033
6.3.1. 2D Bioprocess Containers
6.3.2. 3D Bioprocess Containers
6.3.3. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Bioprocess Containers Market Analysis and Forecast, by Capacity
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Capacity, 2017-2033
7.3.1. Small Volume
7.3.2. Large Volume
7.4. Market Attractiveness Analysis, by Capacity
8. Global Bioprocess Containers Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017-2033
8.3.1. Upstream Processes
8.3.2. Downstream Processes
8.3.3. Process Development
8.4. Market Attractiveness Analysis, by Application
9. Global Bioprocess Containers Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017-2033
9.3.1. Pharmaceutical & Biotechnology Companies
9.3.2. CROs & CMOs
9.3.3. Academic & Research Institutes
9.4. Market Attractiveness Analysis, by End-user
10. Global Bioprocess Containers Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Bioprocess Containers Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017-2033
11.2.1. 2D Bioprocess Containers
11.2.2. 3D Bioprocess Containers
11.2.3. Others
11.3. Market Value Forecast, by Capacity, 2017-2033
11.3.1. Small Volume
11.3.2. Large Volume
11.4. Market Value Forecast, by Application, 2017-2033
11.4.1. Upstream Processes
11.4.2. Downstream Processes
11.4.3. Process Development
11.5. Market Value Forecast, by End-user, 2017-2033
11.5.1. Pharmaceutical & Biotechnology Companies
11.5.2. CROs & CMOs
11.5.3. Academic & Research Institutes
11.6. Market Value Forecast, by Country, 2017-2033
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Capacity
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Bioprocess Containers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017-2033
12.2.1. 2D Bioprocess Containers
12.2.2. 3D Bioprocess Containers
12.2.3. Others
12.3. Market Value Forecast, by Capacity, 2017-2033
12.3.1. Small Volume
12.3.2. Large Volume
12.4. Market Value Forecast, by Application, 2017-2033
12.4.1. Upstream Processes
12.4.2. Downstream Processes
12.4.3. Process Development
12.5. Market Value Forecast, by End-user, 2017-2033
12.5.1. Pharmaceutical & Biotechnology Companies
12.5.2. CROs & CMOs
12.5.3. Academic & Research Institutes
12.6. Market Value Forecast, by Country/Sub-region, 2017-2033
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Capacity
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Bioprocess Containers Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017-2033
13.2.1. 2D Bioprocess Containers
13.2.2. 3D Bioprocess Containers
13.2.3. Others
13.3. Market Value Forecast, by Capacity, 2017-2033
13.3.1. Small Volume
13.3.2. Large Volume
13.4. Market Value Forecast, by Application, 2017-2033
13.4.1. Upstream Processes
13.4.2. Downstream Processes
13.4.3. Process Development
13.5. Market Value Forecast, by End-user, 2017-2033
13.5.1. Pharmaceutical & Biotechnology Companies
13.5.2. CROs & CMOs
13.5.3. Academic & Research Institutes
13.6. Market Value Forecast, by Country/Sub-region, 2017-2033
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Capacity
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Bioprocess Containers Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017-2033
14.2.1. 2D Bioprocess Containers
14.2.2. 3D Bioprocess Containers
14.2.3. Others
14.3. Market Value Forecast, by Capacity, 2017-2033
14.3.1. Small Volume
14.3.2. Large Volume
14.4. Market Value Forecast, by Application, 2017-2033
14.4.1. Upstream Processes
14.4.2. Downstream Processes
14.4.3. Process Development
14.5. Market Value Forecast, by End-user, 2017-2033
14.5.1. Pharmaceutical & Biotechnology Companies
14.5.2. CROs & CMOs
14.5.3. Academic & Research Institutes
14.6. Market Value Forecast, by Country/Sub-region, 2017-2033
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Capacity
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Bioprocess Containers Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017-2033
15.2.1. 2D Bioprocess Containers
15.2.2. 3D Bioprocess Containers
15.2.3. Others
15.3. Market Value Forecast, by Capacity, 2017-2033
15.3.1. Small Volume
15.3.2. Large Volume
15.4. Market Value Forecast, by Application, 2017-2033
15.4.1. Upstream Processes
15.4.2. Downstream Processes
15.4.3. Process Development
15.5. Market Value Forecast, by End-user, 2017-2033
15.5.1. Pharmaceutical & Biotechnology Companies
15.5.2. CROs & CMOs
15.5.3. Academic & Research Institutes
15.6. Market Value Forecast, by Country/Sub-region, 2017-2033
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Type
15.7.2. By Capacity
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2022)
16.3. Company Profiles
16.3.1. Sartorius AG
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Thermo Fisher Scientific Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Danaher Corporation
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Merck KGaA
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Corning Incorporated
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Saint-Gobain
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Avantor, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Parker Hannifin Corporation
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Entegris, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Meissner Filtration Products, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Lonza AG
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. Flexbiosys Inc.
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview
16.3.13. ABEC, Inc.
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Product Portfolio
16.3.13.3. Financial Overview
16.3.13.4. SWOT Analysis
16.3.13.5. Strategic Overview
16.3.14. Cellexus
16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.14.2. Product Portfolio
16.3.14.3. Financial Overview
16.3.14.4. SWOT Analysis
16.3.14.5. Strategic Overview
List of Tables
Table 01: Global Bioprocess Containers Market Value (US$ Mn) Forecast, by Type, 2017-2033
Table 02: Global Bioprocess Containers Market Value (US$ Mn) Forecast, by Capacity, 2017-2033
Table 03: Global Bioprocess Containers Market Value (US$ Mn) Forecast, by Application, 2017-2033
Table 04: Global Bioprocess Containers Market Value (US$ Mn) Forecast, by End-user, 2017-2033
Table 05: Global Bioprocess Containers Market Value (US$ Mn) Forecast, by Region, 2017-2033
Table 06: North America Bioprocess Containers Market Value (US$ Mn) Forecast, by Type, 2017-2033
Table 07: North America Bioprocess Containers Market Value (US$ Mn) Forecast, by Capacity, 2017-2033
Table 08: North America Bioprocess Containers Market Value (US$ Mn) Forecast, by Application, 2017-2033
Table 09: North America Bioprocess Containers Market Value (US$ Mn) Forecast, by End-user, 2017-2033
Table 10: North America Bioprocess Containers Market Value (US$ Mn) Forecast, by Country, 2017-2033
Table 11: Europe Bioprocess Containers Market Value (US$ Mn) Forecast, by Type, 2017-2033
Table 12: Europe Bioprocess Containers Market Value (US$ Mn) Forecast, by Capacity, 2017-2033
Table 13: Europe Bioprocess Containers Market Value (US$ Mn) Forecast, by Application, 2017-2033
Table 14: Europe Bioprocess Containers Market Value (US$ Mn) Forecast, by End-user, 2017-2033
Table 15: Europe Bioprocess Containers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2033
Table 16: Asia Pacific Bioprocess Containers Market Value (US$ Mn) Forecast, by Type, 2017-2033
Table 17: Asia Pacific Bioprocess Containers Market Value (US$ Mn) Forecast, by Capacity, 2017-2033
Table 18: Asia Pacific Bioprocess Containers Market Value (US$ Mn) Forecast, by Application, 2017-2033
Table 19: Asia Pacific Bioprocess Containers Market Value (US$ Mn) Forecast, by End-user, 2017-2033
Table 20: Asia Pacific Bioprocess Containers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2033
Table 21: Latin America Bioprocess Containers Market Value (US$ Mn) Forecast, by Type, 2017-2033
Table 22: Latin America Bioprocess Containers Market Value (US$ Mn) Forecast, by Capacity, 2017-2033
Table 23: Latin America Bioprocess Containers Market Value (US$ Mn) Forecast, by Application, 2017-2033
Table 24: Latin America Bioprocess Containers Market Value (US$ Mn) Forecast, by End-user, 2017-2033
Table 25: Latin America Bioprocess Containers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2033
Table 26: Middle East & Africa Bioprocess Containers Market Value (US$ Mn) Forecast, by Type, 2017-2033
Table 27: Middle East & Africa Bioprocess Containers Market Value (US$ Mn) Forecast, by Capacity, 2017-2033
Table 28: Middle East & Africa Bioprocess Containers Market Value (US$ Mn) Forecast, by Application, 2017-2033
Table 29: Middle East & Africa Bioprocess Containers Market Value (US$ Mn) Forecast, by End-user, 2017-2033
Table 30: Middle East & Africa Bioprocess Containers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2033
List of Figures
Figure 01: Global Bioprocess Containers Market Value (US$ Mn) Forecast, 2017-2033
Figure 02: Bioprocess Containers Market Value Share, by Type, 2022
Figure 03: Bioprocess Containers Market Value Share, by Capacity, 2022
Figure 04: Bioprocess Containers Market Value Share, by Application, 2022
Figure 05: Bioprocess Containers Market Value Share, by End-user, 2022
Figure 06: Bioprocess Containers Market Value Share, by Region, 2022
Figure 07: Global Bioprocess Containers Market Value Share Analysis, by Type, 2022 and 2033
Figure 08: Global Bioprocess Containers Market Attractiveness Analysis, by Type, 2023-2033
Figure 09: Global Bioprocess Containers Market Value (US$ Mn), by 2D Bioprocess Containers, 2017-2033
Figure 10: Global Bioprocess Containers Market Value (US$ Mn), by 3D Bioprocess Containers, 2017-2033
Figure 11: Global Bioprocess Containers Market Value (US$ Mn), by Others, 2017-2033
Figure 12: Global Bioprocess Containers Market Value Share Analysis, by Capacity, 2022 and 2033
Figure 13: Global Bioprocess Containers Market Attractiveness Analysis, by Capacity, 2023-2033
Figure 14: Global Bioprocess Containers Market Value (US$ Mn), by Small Volume, 2017-2033
Figure 15: Global Bioprocess Containers Market Value (US$ Mn), by Large Volume, 2017-2033
Figure 16: Global Bioprocess Containers Market Value Share Analysis, by Application, 2022 and 2033
Figure 17: Global Bioprocess Containers Market Attractiveness Analysis, by Application, 2023-2033
Figure 18: Global Bioprocess Containers Market Revenue (US$ Mn), by Upstream Processes, 2017-2033
Figure 19: Global Bioprocess Containers Market Revenue (US$ Mn), by Downstream Processes, 2017-2033
Figure 20: Global Bioprocess Containers Market Revenue (US$ Mn), by Process Development, 2017-2033
Figure 21: Global Bioprocess Containers Market Value Share Analysis, by End-user, 2022 and 2033
Figure 22: Global Bioprocess Containers Market Attractiveness Analysis, by End-user, 2023-2033
Figure 23: Global Bioprocess Containers Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017-2033
Figure 24: Global Bioprocess Containers Market Revenue (US$ Mn), by CROs & CMOs, 2017-2033
Figure 25: Global Bioprocess Containers Market Revenue (US$ Mn), by Academic & Research Institutes, 2017-2033
Figure 26: Global Bioprocess Containers Market Value Share Analysis, by Region, 2022 and 2033
Figure 27: Global Bioprocess Containers Market Attractiveness Analysis, by Region, 2023-2033
Figure 28: North America Bioprocess Containers Market Value (US$ Mn) Forecast, 2017-2033
Figure 29: North America Bioprocess Containers Value Share Analysis, by Type, 2022 and 2033
Figure 30: North America Bioprocess Containers Attractiveness Analysis, by Type, 2023-2033
Figure 31: North America Bioprocess Containers Market Value Share Analysis, by Capacity, 2022 and 2033
Figure 32: North America Bioprocess Containers Market Attractiveness Analysis, by Capacity, 2023-2033
Figure 33: North America Bioprocess Containers Market Value Share Analysis, by Application, 2022 and 2033
Figure 34: North America Bioprocess Containers Market Attractiveness Analysis, by Application, 2023-2033
Figure 35: North America Bioprocess Containers Value Share Analysis, by End-user, 2022 and 2033
Figure 36: North America Bioprocess Containers Attractiveness Analysis, by End-user, 2023-2033
Figure 37: North America Bioprocess Containers Value Share Analysis, by Country, 2022 and 2033
Figure 38: North America Bioprocess Containers Attractiveness Analysis, by Country, 2023-2033
Figure 39: Europe Bioprocess Containers Market Value (US$ Mn) Forecast, 2017-2033
Figure 40: Europe Bioprocess Containers Value Share Analysis, by Type, 2022 and 2033
Figure 41: Europe Bioprocess Containers Attractiveness Analysis, by Type, 2023-2033
Figure 42: Europe Bioprocess Containers Market Value Share Analysis, by Capacity, 2022 and 2033
Figure 43: Europe Bioprocess Containers Market Attractiveness Analysis, by Capacity, 2023-2033
Figure 44: Europe Bioprocess Containers Market Value Share Analysis, by Application, 2022 and 2033
Figure 45: Europe Bioprocess Containers Market Attractiveness Analysis, by Application, 2023-2033
Figure 46: Europe Bioprocess Containers Value Share Analysis, by End-user, 2022 and 2033
Figure 47: Europe Bioprocess Containers Attractiveness Analysis, by End-user, 2023-2033
Figure 48: Europe Bioprocess Containers Value Share Analysis, by Country/Sub-region, 2022 and 2033
Figure 49: Europe Bioprocess Containers Attractiveness Analysis, by Country/Sub-region, 2023-2033
Figure 50: Asia Pacific Bioprocess Containers Market Value (US$ Mn) Forecast, 2017-2033
Figure 51: Asia Pacific Bioprocess Containers Value Share Analysis, by Type, 2022 and 2033
Figure 52: Asia Pacific Bioprocess Containers Attractiveness Analysis, by Type, 2023-2033
Figure 53: Asia Pacific Bioprocess Containers Market Value Share Analysis, by Capacity, 2022 and 2033
Figure 54: Asia Pacific Bioprocess Containers Market Attractiveness Analysis, by Capacity, 2023-2033
Figure 55: Asia Pacific Bioprocess Containers Market Value Share Analysis, by Application, 2022 and 2033
Figure 56: Asia Pacific Bioprocess Containers Market Attractiveness Analysis, by Application, 2023-2033
Figure 57: Asia Pacific Bioprocess Containers Value Share Analysis, by End-user, 2022 and 2033
Figure 58: Asia Pacific Bioprocess Containers Attractiveness Analysis, by End-user, 2023-2033
Figure 59: Asia Pacific Bioprocess Containers Value Share Analysis, by Country/Sub-region, 2022 and 2033
Figure 60: Asia Pacific Bioprocess Containers Attractiveness Analysis, by Country/Sub-region, 2023-2033
Figure 61: Latin America Bioprocess Containers Market Value (US$ Mn) Forecast, 2017-2033
Figure 62: Latin America Bioprocess Containers Value Share Analysis, by Type, 2022 and 2033
Figure 63: Latin America Bioprocess Containers Attractiveness Analysis, by Type, 2023-2033
Figure 64: Latin America Bioprocess Containers Market Value Share Analysis, by Capacity, 2022 and 2033
Figure 65: Latin America Bioprocess Containers Market Attractiveness Analysis, by Capacity, 2023-2033
Figure 66: Latin America Bioprocess Containers Market Value Share Analysis, by Application, 2022 and 2033
Figure 67: Latin America Bioprocess Containers Market Attractiveness Analysis, by Application, 2023-2033
Figure 68: Latin America Bioprocess Containers Value Share Analysis, by End-user, 2022 and 2033
Figure 69: Latin America Bioprocess Containers Attractiveness Analysis, by End-user, 2023-2033
Figure 70: Latin America Bioprocess Containers Value Share Analysis, by Country/Sub-region, 2022 and 2033
Figure 71: Latin America Bioprocess Containers Attractiveness Analysis, by Country/Sub-region, 2023-2033
Figure 72: Middle East & Africa Bioprocess Containers Market Value (US$ Mn) Forecast, 2017-2033
Figure 73: Middle East & Africa Bioprocess Containers Value Share Analysis, by Type, 2022 and 2033
Figure 74: Middle East & Africa Bioprocess Containers Attractiveness Analysis, by Type, 2023-2033
Figure 75: Middle East & Africa Bioprocess Containers Market Value Share Analysis, by Capacity, 2022 and 2033
Figure 76: Middle East & Africa Bioprocess Containers Market Attractiveness Analysis, by Capacity, 2023-2033
Figure 77: Middle East & Africa Bioprocess Containers Market Value Share Analysis, by Application, 2022 and 2033
Figure 78: Middle East & Africa Bioprocess Containers Market Attractiveness Analysis, by Application, 2023-2033
Figure 79: Middle East & Africa Bioprocess Containers Value Share Analysis, by End-user, 2022 and 2033
Figure 80: Middle East & Africa Bioprocess Containers Attractiveness Analysis, by End-user, 2023-2033
Figure 81: Middle East & Africa Bioprocess Containers Value Share Analysis, by Country/Sub-region, 2022 and 2033
Figure 82: Middle East & Africa Bioprocess Containers Attractiveness Analysis, by Country/Sub-region, 2023-2033
Figure 83: Company Share Analysis, 2022
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Bioprocess Containers Market
*86 figures and 60 tables includes